Literature DB >> 22045700

Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults.

Daniel C Beachler1, Kathleen M Weber, Joseph B Margolick, Howard D Strickler, Ross D Cranston, Robert D Burk, Dorothy J Wiley, Howard Minkoff, Susheel Reddy, Emily E Stammer, Maura L Gillison, Gypsyamber D'Souza.   

Abstract

INTRODUCTION: Human papillomavirus (HPV) is an important risk factor for oropharyngeal cancer. Individuals with human immunodeficiency virus (HIV) have higher oral HPV prevalence but the risk factors for oral HPV infection are not well understood for either HIV-positive or HIV-negative individuals.
METHODS: This study was nested within the Multicenter AIDS Cohort Study (MACS; men) and Women Interagency HIV Study (WIHS; women) cohorts. Exfoliated oral epithelial cells were collected from 379 HIV-positive and 266 at-risk HIV-negative individuals using a rinse and gargle with Scope mouthwash. Samples were tested for 36 types of HPV DNA using PGMY09/11 consensus primers and reverse line blot hybridization. Risk factors for oral HPV infection were explored using logistic regression with generalized estimating equations in this cross-sectional analysis.
RESULTS: Prevalent oral HPV infection was common (34%), including HPV16 infection in 5.7% of participants. HIV-positive individuals had increased odds of prevalent oral HPV infection compared with HIV-negative individuals [adjusted OR = 2.1; 95% confidence interval (CI), 1.6-2.8]. Risk factors for prevalent oral HPV differed in HIV-positive and HIV-negative participants. Among HIV-negative individuals, higher number of recent oral sex or rimming partners were strong risk factors for prevalent oral HPV infection (each P(trend) < 0.01). In contrast, among HIV-positive individuals, lower CD4 T-cell count (P(trend) < 0.001) and higher number of lifetime sexual partners (P(trend) = 0.03) were strong risk factors.
CONCLUSIONS: Oral HPV prevalence was elevated in HIV-positive individuals after controlling for differences in cigarette smoking and sexual behavior, supporting the possibility that HIV may affect the natural history of oral HPV. IMPACT: Immunosuppression may contribute to increased persistence or progression of oral HPV infection.

Entities:  

Mesh:

Year:  2011        PMID: 22045700      PMCID: PMC3280125          DOI: 10.1158/1055-9965.EPI-11-0734

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  57 in total

1.  Effect of highly active antiretroviral therapy on frequency of oral warts.

Authors:  D Greenspan; A J Canchola; L A MacPhail; B Cheikh; J S Greenspan
Journal:  Lancet       Date:  2001-05-05       Impact factor: 79.321

2.  Carcinogenicity of human papillomaviruses.

Authors:  Vincent Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

3.  Recruiting minority men who have sex with men for HIV research: results from a 4-city campaign.

Authors:  Anthony J Silvestre; John B Hylton; Lisette M Johnson; Carmoncelia Houston; Mallory Witt; Lisa Jacobson; David Ostrow
Journal:  Am J Public Health       Date:  2006-05-02       Impact factor: 9.308

4.  The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults.

Authors:  Jennifer E Cameron; Donald Mercante; Megan O'Brien; Ann M Gaffga; Janet E Leigh; Paul L Fidel; Michael E Hagensee
Journal:  Sex Transm Dis       Date:  2005-11       Impact factor: 2.830

5.  Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study.

Authors:  T E Wilson; L S Massad; K A Riester; S Barkan; J Richardson; M Young; A Gurtman; R Greenblatt
Journal:  AIDS       Date:  1999-04-01       Impact factor: 4.177

Review 6.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

7.  Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.

Authors:  Carole Fakhry; Gypsyamber D'souza; Elizabeth Sugar; Kathleen Weber; Eleni Goshu; Howard Minkoff; Rodney Wright; Eric Seaberg; Maura Gillison
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

Review 8.  Oral human papillomavirus in healthy individuals: a systematic review of the literature.

Authors:  Aimée R Kreimer; Rohini K Bhatia; Andrea L Messeguer; Paula González; Rolando Herrero; Anna R Giuliano
Journal:  Sex Transm Dis       Date:  2010-06       Impact factor: 2.830

9.  Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women.

Authors:  Amanda J Durante; Ann B Williams; Maria Da Costa; Teresa M Darragh; Kaveh Khoshnood; Joel M Palefsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-07       Impact factor: 4.254

Review 10.  Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?

Authors:  Erich M Sturgis; Paul M Cinciripini
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860

View more
  87 in total

Review 1.  Epidemiology and clinical aspects of HPV in head and neck cancers.

Authors:  Anil K Chaturvedi
Journal:  Head Neck Pathol       Date:  2012-07-03

2.  Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.

Authors:  Lesley S Park; Raúl U Hernández-Ramírez; Michael J Silverberg; Kristina Crothers; Robert Dubrow
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

3.  Smoking increases oral HPV persistence among men: 7-year follow-up study.

Authors:  K Kero; J Rautava; K Syrjänen; J Willberg; S Grenman; S Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-13       Impact factor: 3.267

Review 4.  Discussing the diagnosis of HPV-OSCC: common questions and answers.

Authors:  Carole Fakhry; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2013-07-19       Impact factor: 5.337

5.  Tailored immunotherapy for HPV positive head and neck squamous cell cancer.

Authors:  Neil Gildener-Leapman; John Lee; Robert L Ferris
Journal:  Oral Oncol       Date:  2013-10-11       Impact factor: 5.337

6.  A cautionary tale: risk reduction strategies among urban American Indian/Alaska Native men who have sex with men.

Authors:  Cynthia R Pearson; Karina L Walters; Jane M Simoni; Ramona Beltran; Kimberly M Nelson
Journal:  AIDS Educ Prev       Date:  2013-02

7.  Epidemiology of head and neck squamous cell cancer among HIV-infected patients.

Authors:  Gypsyamber Dʼsouza; Thomas E Carey; William N William; Minh Ly Nguyen; Eric C Ko; James Riddell; Sara I Pai; Vishal Gupta; Heather M Walline; J Jack Lee; Gregory T Wolf; Dong M Shin; Jennifer R Grandis; Robert L Ferris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

8.  Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.

Authors:  Gypsyamber D'Souza; Neil D Gross; Sara I Pai; Robert Haddad; Karen S Anderson; Shirani Rajan; Jennifer Gerber; Maura L Gillison; Marshall R Posner
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

9.  Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.

Authors:  Daniel C Beachler; Elizabeth A Sugar; Joseph B Margolick; Kathleen M Weber; Howard D Strickler; Dorothy J Wiley; Ross D Cranston; Robert D Burk; Howard Minkoff; Susheel Reddy; Weihong Xiao; Yingshi Guo; Maura L Gillison; Gypsyamber D'Souza
Journal:  Am J Epidemiol       Date:  2014-12-04       Impact factor: 4.897

10.  HPV-associated oropharyngeal cancer: Knowledge and attitude/beliefs among non-clinical staff at community-based HIV/AIDS Service Organizations (ASO) in the south United States (U.S.) census region.

Authors:  Aditi Tomar; Hannah C Balcezak; Lisa T Wigfall
Journal:  Health Soc Care Community       Date:  2020-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.